NL-OMON55653招募中不适用
The BITE study - Bleeding In Thrombocytopenia Explained: A nationwide epidemiological and laboratory case cohort study investigating risk factors for bleeding in hemato-oncology patients - The BITE study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- 观察性
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- Admission in the hospital
- AND
- Age >= 18 years
- AND
- Hemato-oncology patient, including MDS and AA, admitted for treatment
- (chemotherapy, SCT) who is (expected to become) thrombocytopenic with platelet
- counts of < 50 for expected at least 5 days and who will possibly be treated
- with one or more prophylactic platelet transfusions. (part A and B)
- OR
- Hemato-oncology patient who had previous intensive chemotherapy or stem cell
- transplantation and who is admitted to the hematology ward for disease or
- treatment related events or complications. (part A only)
排除标准
- Myeloproliferative disorders
研究者
标识符
- 注册编号
- NL-OMON55653
- 其他研究编号
- 62499.058.17
日期
- 最近更新
- (2年前)
监管与共享
- 是否有结果
- 否